MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2016 International Congress

    Influence of onset age on the progression of non-motor symptoms in Parkinson’s disease: A prospective study from Southwest China

    R. Ou, B. Cao, Q. Wei, K. Chen, W. Song, J. Yang, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)

    Objective: To explore the influence of onset age on the progression of non-motor symptoms (NMS) in Parkinson's disease. Background: NMS are gaining increasing relevance in…
  • 2016 International Congress

    Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease

    H.S. Dafsari, L. Weiss, M. Silverdale, P. Reddy, A. Rizos, M. Samuel, E. Perrier, J. Evans, K. Ashkan, J.N. Petry-Schmelzer, V. Visser-Vandewalle, A. Antonini, P. Martinez-Martin, K.R. Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To investigate non-motor symptoms (NMS) to find contributing factors for quality of life (QoL) outcome after subthalamic nucleus (STN) deep brain stimulation (DBS) in…
  • 2016 International Congress

    Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong

    H.F. Chan, Y.F. Cheung, D.K.W. Chau, T. Fung, I. Chan, W.C. Fong (Hong Kong, Hong Kong)

    Objective: 1. To evaluate the quality of life (QoL) profile of Parkinson's disease (PD) patients in a multidisciplinary clinic in a tertiary hospital in Hong…
  • 2016 International Congress

    Multicenter report of clinical use of a non-motor symptom questionnaire for craniocervical dystonia: The DNMS quest

    L. Klingelhoefer, M. Kaiser, D. Martino, L. Perkins, M. Wienecke, A. Sauerbier, R. Untucht, D. Trivedi, K. Mammadova, T. Chiwera, A. Rizos, P. Martinez-Martin, H. Reichmann, K.R. Chaudhuri (Dresden, Germany)

    Objective: To validate a non motor symptom (NMS) questionnaire in patients with craniocervical dystonia (CCD). Background: We have reported the clinical use of a Dystonia…
  • 2016 International Congress

    Comorbidity and Parkinson’s disease phenotype, dopaminergic function and CSF biomarkers

    T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To evaluate the influence of comorbidity on clinical phenotype, dopaminergic function and CSF biomarkers in a population of de novo Parkinson's disease (PD) patients.…
  • 2016 International Congress

    The non-motors symptoms in Parkinson’s disease patients with freezing of gait

    H.C. Huang, M.K. Lu, C.H. Tsai (Taichung, Taiwan)

    Objective: To reveal the prevalence of the non-motors symptoms and clinical features differences between Parkinson's disease (PD) patients with and without freezing of gait (FOG).…
  • 2016 International Congress

    Quality of life and living with Parkinson’s in Ireland

    I. Cassidy, P. Meskell, M.P. Butler, M. Richardson, C. Kennedy, S. Coote, P. Boers (Limerick, Ireland)

    Objective: (1) Assess the quality of life (QoL) for people with Parkinson's and explore associations between (QoL) and demographics (2) Investigate incidence of depression and…
  • 2016 International Congress

    Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

    J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To assess the clinimetric properties of the Hebrew version of the MDS-UPDRS. Background: The Unified Parkinson's disease Rating Scale (UPDRS) is a rating scale…
  • 2016 International Congress

    J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms

    T. Maeda, Y. Shimo, S.W. Chiu, T. Yamaguchi, K. Kashihara, Y. Tsuboi, M. Nomoto, N. Hattori, H. Watanabe, H. Saiki (Akita, Japan)

    Objective: To clarify the clinical manifestations of nonmotor symptoms (NMSs) and identify factors affecting NMSs and quality of life (QOL) in Japanese patients with Parkinson's…
  • 2016 International Congress

    Impulse control disorders after STN DBS for Parkinson’s disease

    P.G. Frederic, P. Camille, J. Nicolas, S. Abbas, F. Maria, P. Michel (Montreal, QC, Canada)

    Objective: To evaluate the prevalence and severity of impulse control disorders (ICD) and other impulsive-compulsive behaviors (ICB) in a cohort of patients with Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley